Inventor · disambiguated record
Gang Liu
Also filed as: LIU GANG · LIU GANG L · LIU GANG LOGAN
114 granted patents·70 pending applications·1,467 citations·filing 1996–2025
99Inventor score
Top patents by PatentIndex Score
184 records- 0196US11603365B2Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamideUNIV TEXAS·Filed 2020·Granted Mar 14, 2023·4 cites·30 claims
- 0296US11370786B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2020·Granted Jun 28, 2022·6 cites·17 claims
- 0396US7419975B2Organic compoundsNOVARTIS AG·Filed 2005·Granted Sep 2, 2008·80 cites·10 claims
- 0496US6645990B2Thiazolyl urea compounds and methods of usesAMGEN INC·Filed 2002·Granted Nov 11, 2003·172 cites·18 claims
- 0595US11958849B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2022·Granted Apr 16, 2024·2 cites·12 claims
- 0695US10899740B2Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido)pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamideUNIV TEXAS·Filed 2019·Granted Jan 26, 2021·8 cites·15 claims
- 0795US7365093B2Endothelin antagonistsABBOTT LAB·Filed 2005·Granted Apr 29, 2008·18 cites·1 claims
- 0895US7196104B2Thiazolyl urea compounds and methods of usesAMGEN INC·Filed 2003·Granted Mar 27, 2007·120 cites·13 claims
- 0994US10766892B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2019·Granted Sep 8, 2020·9 cites·26 claims
- 1094US10150753B2Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyrdin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamideUNIV TEXAS·Filed 2016·Granted Dec 11, 2018·7 cites·15 claims
- 1194US9176065B2Nanoscale array structures suitable for surface enhanced raman scattering and methods related theretoL LIVERMORE NAT SECURITY LLC·Filed 2014·Granted Nov 3, 2015·16 cites·30 claims
- 1294US6515140B2Fused pyrrolecarboxamides; a new class of GABA brain receptor ligandsNEUROGEN CORP·Filed 2001·Granted Feb 4, 2003·33 cites·2 claims
- 1393US9809588B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2015·Granted Nov 7, 2017·15 cites·27 claims
- 1493US6946481B1Endothelin antagonistsABBOTT LAB·Filed 2002·Granted Sep 20, 2005·37 cites·26 claims
- 1593US6399604B1Substituted 4-OXO-napthyridine-3-carboxamides; GABA brain receptor ligandsNEUROGEN CORP·Filed 2000·Granted Jun 4, 2002·33 cites·107 claims
- 1692US10344025B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2017·Granted Jul 9, 2019·12 cites·11 claims
- 1792US7119205B2Thienopyridones as AMPK activators for the treatment of diabetes and obesityABBOTT LAB·Filed 2004·Granted Oct 10, 2006·47 cites·14 claims
- 1892US6646124B2Substituted 4-oxo-napthyridine-3-carboxamides: GABA brain receptor ligandsNEUROGEN CORP·Filed 2002·Granted Nov 11, 2003·24 cites·8 claims
- 1992US6162927AEndothelin antagonistsABBOTT LAB·Filed 1997·Granted Dec 19, 2000·46 cites·10 claims
- 2092US6143760ASubstituted 4-oxo-napthyridine-3-carboxamides: GABA brain receptor ligandsNEUROGEN CORP·Filed 1998·Granted Nov 7, 2000·47 cites·110 claims
- 2191US10829484B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Nov 10, 2020·5 cites·21 claims
- 2290US7169797B2Protein-tyrosine phosphatase inhibitors and uses thereofABBOTT LAB·Filed 2004·Granted Jan 30, 2007·33 cites·12 claims
- 2390US6297256B1Aryl and heteroaryl substituted pyridino derivatives GABA brain receptor ligandsNEUROGEN CORP·Filed 2000·Granted Oct 2, 2001·26 cites·22 claims
- 2489US9115120B2Heterocyclic modulators of HIF activity for treatment of diseaseUNIV TEXAS·Filed 2013·Granted Aug 25, 2015·9 cites·9 claims
- 2589US9080981B2Nanoscale array structures suitable for surface enhanced raman scattering and methods related theretoL LIVERMORE NAT SECURITY LLC·Filed 2014·Granted Jul 14, 2015·6 cites·18 claims
- 2689US7208517B1Endothelin antagonistsABBOTT LABORTORIES·Filed 2000·Granted Apr 24, 2007·35 cites·8 claims
- 2789US5723462ACertain fused pyrrolecarboxamides a new class of GABA brain receptor ligandsNEUROGEN CORP·Filed 1996·Granted Mar 3, 1998·41 cites·11 claims
- 2888US6423711B1Heterocyclic amino substituted heteroaryl fused pyridines; GABA brain receptor ligandsNEUROGEN CORP·Filed 2000·Granted Jul 23, 2002·23 cites·23 claims
- 2987US8557830B2RAF kinase modulators and methods of useSMITH ADRIAN L·Filed 2008·Granted Oct 15, 2013·10 cites·13 claims
- 3087US6103903A4-(4-piperidylmethyhlamino) substituted heteroaryl fused pyridines: GABA brain receptor ligandsNEUROGEN CORP·Filed 1999·Granted Aug 15, 2000·34 cites·19 claims
- 3186US10287266B2Compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2016·Granted May 14, 2019·8 cites·13 claims
- 3286US8349851B2JAK kinase modulating compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2010·Granted Jan 8, 2013·9 cites·19 claims
- 3386US6462194B1Endothelin antagonistsABBOTT LAB·Filed 2000·Granted Oct 8, 2002·14 cites·9 claims
- 3486US6380241B1Treatment of diseases using endothelin antagonistsABBOTT LAB·Filed 2000·Granted Apr 30, 2002·13 cites·6 claims
- 3586US6380209B14-(4-piperidylmethylamino) substituted heteroaryl fused pyridines: GABA brain receptor ligandsNEUROGEN CORP·Filed 2000·Granted Apr 30, 2002·15 cites·13 claims
- 3686US6211365B1Fused pyrrolecarboxamides; a new class of GABA brain receptor ligandsNEUROGEN CORP·Filed 1999·Granted Apr 3, 2001·29 cites·10 claims
- 3786US2024360121A1Gls1 inhibitors for treating diseaseUNIV TEXAS·Filed 2024·Application pending·0 cites
- 3885US10899769B2Imidazopiperazinone inhibitors of transcription activating proteinsUNIV TEXAS·Filed 2019·Granted Jan 26, 2021·3 cites·26 claims
- 3985US10093664B2Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of diseaseUNIV TEXAS·Filed 2017·Granted Oct 9, 2018·4 cites·24 claims
- 4085US8957068B23-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDHCAFERRO THOMAS RAYMOND·Filed 2012·Granted Feb 17, 2015·13 cites·28 claims
- 4185US7989461B2Substituted quinazolinamine compounds for the treatment of cancerAMGEN INC·Filed 2006·Granted Aug 2, 2011·9 cites·14 claims
- 4285US6994971B1Particle analysis assay for biomolecular quantificationUNIV UTAH RES FOUND·Filed 2000·Granted Feb 7, 2006·14 cites·5 claims
- 4384US12252480B2Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamideUNIV TEXAS·Filed 2023·Granted Mar 18, 2025·0 cites·10 claims
- 4484US9434719B23-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDHCAFERRO THOMAS RAYMOND·Filed 2014·Granted Sep 6, 2016·7 cites·16 claims
- 4584US8149397B2Metallic nanostructures adapted for electromagnetic field enhancementLEE LUKE P·Filed 2006·Granted Apr 3, 2012·12 cites·19 claims
- 4684US7888374B2Inhibitors of c-jun N-terminal kinasesABBOTT LAB·Filed 2006·Granted Feb 15, 2011·9 cites·23 claims
- 4783US7943652B2Hydroxamate-based inhibitors of deacetylases BNOVARTIS AG·Filed 2009·Granted May 17, 2011·6 cites·42 claims
- 4883US6878700B1Cell adhesion-inhibiting antiinflammatory and immune-suppressive compoundsABBOTT LAB·Filed 2000·Granted Apr 12, 2005·14 cites·7 claims
- 4983US6720339B2Certain fused pyrrolecarboxamides; a new class of GABA brain receptor ligandsNEUROGEN CORP·Filed 2002·Granted Apr 13, 2004·11 cites·47 claims
- 5083US6627767B2Amino(oxo) acetic acid protein tyrosine phosphatase inhibitorsABBOTT LAB·Filed 2001·Granted Sep 30, 2003·15 cites·24 claims
Showing the top 50 of 184 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →